Advanced company searchLink opens in new window

SYNEXUS CLINICAL RESEARCH MIDCO NO 4 LIMITED

Company number 06408416

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
26 Apr 2022 GAZ2(A) Final Gazette dissolved via voluntary strike-off
08 Feb 2022 GAZ1(A) First Gazette notice for voluntary strike-off
01 Feb 2022 DS01 Application to strike the company off the register
29 Dec 2021 AP01 Appointment of Mr Richard Stuart Harris as a director on 29 December 2021
29 Dec 2021 TM01 Termination of appointment of Brainard Judd Hartman as a director on 8 December 2021
01 Dec 2021 PSC05 Change of details for Synexus Clinical Research Midco No 3 Limited as a person with significant control on 1 December 2021
01 Dec 2021 AD01 Registered office address changed from Sandringham House Ackhurst Park Chorley Lancashire PR7 1NY to 12B Granta Park Great Abington, Cambridge CB21 6GQ on 1 December 2021
22 Oct 2021 CS01 Confirmation statement made on 14 September 2021 with no updates
07 Jan 2021 AA Full accounts made up to 31 December 2019
21 Sep 2020 CS01 Confirmation statement made on 14 September 2020 with no updates
03 Jul 2020 AD02 Register inspection address has been changed to Eversheds Sutherland (International) Llp 70 Great Bridgewater Street Manchester M1 5ES
13 Mar 2020 TM01 Termination of appointment of Christopher David Neild as a director on 13 March 2020
11 Oct 2019 AA Full accounts made up to 31 December 2018
30 Sep 2019 CS01 Confirmation statement made on 14 September 2019 with no updates
06 Oct 2018 AA Full accounts made up to 31 December 2017
20 Sep 2018 CS01 Confirmation statement made on 14 September 2018 with no updates
03 Oct 2017 AA Full accounts made up to 31 December 2016
21 Sep 2017 CS01 Confirmation statement made on 14 September 2017 with updates
19 Sep 2016 CS01 Confirmation statement made on 14 September 2016 with updates
31 Aug 2016 SH20 Statement by Directors
31 Aug 2016 SH19 Statement of capital on 31 August 2016
  • GBP 0.01
31 Aug 2016 CAP-SS Solvency Statement dated 31/08/16
31 Aug 2016 RESOLUTIONS Resolutions
  • RES06 ‐ Resolution of reduction in issued share capital
  • RES13 ‐ The share premium account be reduced. 31/08/2016
13 Jun 2016 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
06 Jun 2016 AP01 Appointment of Mr Brainard Judd Hartman as a director on 31 May 2016